CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
Operating activities:
Net earnings	$ 13,438	$ 12,975
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	2,133	2,090
Deferred income tax expense	309	398
Gross excess tax benefit from exercise of stock options and vesting of restricted stock units	(407)	(286)
Stock-based compensation expense on equity awards	1,076	1,075
Gain from life insurance policies	(2,358)	0
Change in customer return and program accruals	696	3,827
Changes in:
Accounts receivable, gross	(2,051)	(6,018)
Inventory	669	4,515
Prepaid expenses and other assets	114	(341)
Accounts payable	(3,509)	(6,890)
Accrued expenses	(810)	(110)
Accrued retirement costs and other	(455)	109
Net cash provided by operating activities	8,845	11,344
Investing activities:
Proceeds from the sale of short-term investments	14,369	26,188
Purchases of short-term investments	(12,227)	(13,896)
Proceeds from life insurance policies	5,533	0
Purchases of property, plant and equipment	(814)	(828)
Net cash provided by investing activities	6,861	11,464
Financing activities:
Repayment of short-term notes payable	0	(1,750)
Principal repayment of long-term debt	(3,214)	(3,214)
Proceeds from stock options exercised	63	25
Gross excess tax benefit from exercise of stock options and vesting of restricted stock units	407	286
Repurchase of common shares	(4,000)	0
Dividends paid	(3,190)	(2,821)
Net cash used in financing activities	(9,934)	(7,474)
Net increase in cash and cash equivalents	5,772	15,334
Cash and cash equivalents at the beginning of the period	21,806	16,112
Cash and cash equivalents at the end of the period	$ 27,578	$ 31,446